Net inflow of ETH 1000 pieces
The resolution of the current ETH net inflow of 1,000 pieces focuses on the following aspects: firstly, some analysts believe that ETH is currently in a small-level range adjustment stage, with the overall weakness, but there is still a possibility of repair. They are concerned about the support of the key price range of 3400-3420 below ETH, and believe that whether the support of the range can be effective will determine whether the next step is to continue to repair or accelerate the decline. Secondly, some analysts believe that the resistance level of ETH is at 3550-3600, and the short-term trend is expected to remain unchanged, the market volatility price will still remain in the range of 3600 below 3100 above the oscillation and finishing. They suggest that partners with short ideas can look for shorting signals to enter the market near the resistance, while partners looking for long opportunities need to be tested in the 3100 to 3200 range is valid and give long buy signals to enter the long side. Finally, some analysts believe that the hodler ratio of ETH exceeds that of BTC as many BTC holders gained profits after reaching the new ATH. They believe that when ETH breaks the previous ATH, ETH traders will follow suit. Overall, the current parse of 1,000 net inflows into ETH is more cautious, with most analysts believing that ETH will continue to oscillate in the short term, but still has upside potential.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
